$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2023 Q4 Form 10-Q Financial Statement

#000118518523001187 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.642M $1.376M
YoY Change 12.25% -5.36%
Cost Of Revenue $384.5K $270.0K
YoY Change 1.96% 12.71%
Gross Profit $1.258M $1.110M
YoY Change 15.82% -8.6%
Gross Profit Margin 76.59% 80.67%
Selling, General & Admin $944.0K $950.0K
YoY Change -15.05% 1.3%
% of Gross Profit 75.05% 85.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.530K $8.936K
YoY Change -30.6% -7.5%
% of Gross Profit 0.6% 0.81%
Operating Expenses $953.9K $1.229M
YoY Change -14.99% 3.54%
Operating Profit $304.0K $147.0K
YoY Change -943.6% -44.93%
Interest Expense $108.0K $100.0K
YoY Change 296.91%
% of Operating Profit 35.52% 68.02%
Other Income/Expense, Net $4.524K
YoY Change 56.11%
Pretax Income $411.9K $249.0K
YoY Change -4759.73% -6.71%
Income Tax $130.6K $69.90K
% Of Pretax Income 31.71% 28.07%
Net Earnings $281.3K $179.1K
YoY Change -2409.28% -6.71%
Net Earnings / Revenue 17.13% 13.02%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.02 $0.01
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.44M $10.13M
YoY Change -3.16% -4.79%
Cash & Equivalents $2.566M $2.360M
Short-Term Investments $7.878M $7.770M
Other Short-Term Assets $218.6K $270.0K
YoY Change 24.64% 71.6%
Inventory
Prepaid Expenses $179.7K $189.4K
Receivables $1.053M $832.8K
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.68M $11.23M
YoY Change -1.81% -3.69%
LONG-TERM ASSETS
Property, Plant & Equipment $77.39K $73.88K
YoY Change -20.54% -15.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $7.110K
YoY Change 7.69% 7.69%
Total Long-Term Assets $141.0K $80.99K
YoY Change -8.53% -13.48%
TOTAL ASSETS
Total Short-Term Assets $11.68M $11.23M
Total Long-Term Assets $141.0K $80.99K
Total Assets $11.82M $11.31M
YoY Change -1.9% -3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $159.8K $121.9K
YoY Change -39.25% 36.48%
Accrued Expenses $367.6K $314.7K
YoY Change 10.54% 27.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.008M $776.5K
YoY Change 42.24% 84.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.97K $0.00
YoY Change 13.78%
Total Long-Term Liabilities $11.97K $0.00
YoY Change 13.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.008M $776.5K
Total Long-Term Liabilities $11.97K $0.00
Total Liabilities $1.020M $792.2K
YoY Change 38.8% 84.83%
SHAREHOLDERS EQUITY
Retained Earnings $10.37M $10.09M
YoY Change -4.72% -7.4%
Common Stock $12.80K $12.80K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.80M $10.52M
YoY Change
Total Liabilities & Shareholders Equity $11.82M $11.31M
YoY Change -1.9% -3.77%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $281.3K $179.1K
YoY Change -2409.28% -6.71%
Depreciation, Depletion And Amortization $7.530K $8.936K
YoY Change -30.6% -7.5%
Cash From Operating Activities $502.4K $160.0K
YoY Change 261.59% -30.99%
INVESTING ACTIVITIES
Capital Expenditures $17.52K $0.00
YoY Change -17.55% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$285.7K $0.00
YoY Change -96.72%
Cash From Investing Activities -$293.2K $0.00
YoY Change -96.65% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 410.0 -100.0K
YoY Change
NET CHANGE
Cash From Operating Activities 502.4K 160.0K
Cash From Investing Activities -293.2K 0.000
Cash From Financing Activities 410.0 -100.0K
Net Change In Cash 209.6K 60.00K
YoY Change -102.44% -74.07%
FREE CASH FLOW
Cash From Operating Activities $502.4K $160.0K
Capital Expenditures $17.52K $0.00
Free Cash Flow $484.8K $160.0K
YoY Change 312.0% -31.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50009
dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
721-8272
dei Security12b Title
Security12bTitle
None
dei Trading Symbol
TradingSymbol
N/A
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2359882 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036432 usd
CY2023Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7769403 usd
CY2022Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8748435 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9302 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7807 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
832826 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
934990 usd
CY2023Q3 us-gaap Other Receivables
OtherReceivables
0 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
82000 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
189445 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175355 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
11233556 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
11898212 usd
CY2023Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
259334 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256500 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20328 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
280954 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
207075 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73879 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97405 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6602 usd
CY2023Q3 us-gaap Assets
Assets
11314545 usd
CY2022Q4 us-gaap Assets
Assets
12052356 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
121925 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263022 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
314687 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
193258 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3132 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
109333 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
37000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
37315 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
776518 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
708869 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2023Q3 us-gaap Liabilities
Liabilities
792197 usd
CY2022Q4 us-gaap Liabilities
Liabilities
735065 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10093475 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10888418 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10522348 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11314545 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12052356 usd
CY2023Q3 us-gaap Revenues
Revenues
1376039 usd
CY2022Q3 us-gaap Revenues
Revenues
1453997 usd
us-gaap Revenues
Revenues
3987576 usd
us-gaap Revenues
Revenues
4281831 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8936 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9661 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27652 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23153 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1265 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-5520 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2429 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-737 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56418 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56148 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
173235 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
166309 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
638288 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
699026 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1927044 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2018638 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
89677 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
76065 usd
us-gaap Professional Fees
ProfessionalFees
263880 usd
us-gaap Professional Fees
ProfessionalFees
222703 usd
CY2023Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
81003 usd
CY2022Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
79974 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
229599 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
238851 usd
CY2023Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
180579 usd
CY2022Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
156677 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
529861 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
433275 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
4524 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
2898 usd
us-gaap Other Expenses
OtherExpenses
69278 usd
us-gaap Other Expenses
OtherExpenses
59400 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
168344 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
112135 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
390019 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
418079 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1229034 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1187064 usd
us-gaap Operating Expenses
OperatingExpenses
3612997 usd
us-gaap Operating Expenses
OperatingExpenses
3579671 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
147005 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
266933 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
374579 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
702160 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
102017 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
301991 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
102017 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
301991 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
249022 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
266933 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
676570 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
702160 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69901 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74928 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
189913 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197096 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
179121 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
192005 usd
us-gaap Net Income Loss
NetIncomeLoss
486657 usd
us-gaap Net Income Loss
NetIncomeLoss
505064 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11012940 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
124524 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11137464 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
192005 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
11329469 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176427 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1280000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10343227 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
179121 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10522348 usd
us-gaap Net Income Loss
NetIncomeLoss
486657 usd
us-gaap Net Income Loss
NetIncomeLoss
505064 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27652 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23153 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2429 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-737 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
126422 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-99735 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-64657 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-10055 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-14090 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-60359 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-19779 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-3000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
82000 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-20186 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-141097 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
44438 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17864 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-68221 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3771 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6979 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
190126 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7316 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
431389 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
572310 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-8748435 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7642981 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4126 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17619 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1101328 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17619 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1209267 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1209267 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
323450 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
554691 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2359882 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10640063 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
82000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
170000 usd
us-gaap Dividends
Dividends
72333 usd
us-gaap Dividends
Dividends
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9302 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7807 usd
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
10714 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
9903 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
31407 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
19806 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2023Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-06-05
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
us-gaap Dividends Cash
DividendsCash
1281600 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
72333 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
pfho-20230930_cal.xml Edgar Link unprocessable
0001185185-23-001187-index-headers.html Edgar Link pending
0001185185-23-001187-index.html Edgar Link pending
0001185185-23-001187.txt Edgar Link pending
0001185185-23-001187-xbrl.zip Edgar Link pending
ex_595392.htm Edgar Link pending
ex_595393.htm Edgar Link pending
ex_595394.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20230930_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pfho-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pfho-20230930_def.xml Edgar Link unprocessable
pfho-20230930_pre.xml Edgar Link unprocessable
pfho-20230930_lab.xml Edgar Link unprocessable
pacifichco20230930_10q_htm.xml Edgar Link completed